| Literature DB >> 35911141 |
Hongqing Su1, Yuexian Wen1, Dandan Kang2.
Abstract
After surgical treatment, the gastrointestinal function of tumor patients is inhibited for a short time. Refined nursing is beneficial to the recovery of gastrointestinal function of tumor patients after operation. Traditional Chinese medicine and Western medicine have their own advantages in the treatment of gastrointestinal dysfunction after tumor operation and the combined application of the two is more ideal. Therefore, on the premise of refined nursing, we should carefully study the efficacy of integrated traditional Chinese and Western medicine in the treatment of postoperative gastrointestinal dysfunction in tumor patients. Fifty patients with gastrointestinal dysfunction after tumor surgery admitted to Xiamen University Affiliated Zhongshan Hospital from June 2021 to August 2022 were retrospectively selected. Twenty two of them received refined care + Western medicine (control group, CG) and the other 28 received refined care + Western medicine + moxibustion and thumb-tack needle Chinese medicine (observation group, OG). We compared the recovery of gastrointestinal function, inflammatory factors, negative emotions, sleep quality, length of stay, medical expenses, and adverse reactions. The postoperative recovery effect of gastrointestinal function in the OG was better than that in the CG. The IL-8 level and TNF -α level in OG were lower than those in CG. Relative to CG, the OG had significantly low SDS scores, SAS scores, PSQ1 scores, length of hospital stay, and medical expenses. The OG incidence of adverse reactions was 28.57%; it was significantly lower than 59.09% in the CG. Refined nursing with integrated Chinese and Western medicine therapeutic interventions can promote the recovery of gastrointestinal tract function, relieve anxiety and depression, and improve sleep quality in patients with postoperative gastrointestinal dysfunction after tumor surgery.Entities:
Year: 2022 PMID: 35911141 PMCID: PMC9328967 DOI: 10.1155/2022/4957061
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1The schematic diagram of the study.
Baseline data [n (%), M ± SD].
| Data | CG ( | OG ( |
|
| |
|---|---|---|---|---|---|
| Gender | Men | 13 | 18 | 0.141 | >0.05 |
| Women | 9 | 10 | |||
|
| |||||
| Age (years) | 28∼54 | 29∼60 | 0.789 | >0.05 | |
| 46.32 ± 8.53 | 44.25 ± 9.71 | ||||
| BMI (kg/m2) | 25.65 ± 6.26 | 25.75 ± 2.06 | 0.079 | >0.05 | |
|
| |||||
| Education level | Primary school and below | 4 | 3 | 0.681 | >0.05 |
| Middle school | 5 | 7 | |||
| High school | 5 | 8 | |||
| College degree or above | 8 | 10 | |||
|
| |||||
| Place of residence | City | 6 | 8 | 0.010 | >0.05 |
| Countryside | 16 | 20 | |||
|
| |||||
| Disease type | Stomach cancer | 7 | 12 | 3.547 | >0.05 |
| Colorectal cancer | 1 | 3 | |||
| Pancreatic cancer | 6 | 4 | |||
| Esophageal cancer | 5 | 3 | |||
| Primary liver cancer | 3 | 6 | |||
|
| |||||
| Family history | Yes | 7 | 6 | 0.691 | >0.05 |
| No | 15 | 22 | |||
Family history refers to the development of the disease in family members (a larger range of family members, not limited to immediate family members such as grandchildren) of patients with gastric, colorectal, pancreatic, esophageal, and primary liver cancers. Some patients have hypertension, diabetes, or other underlying diseases.
Comparison of gastrointestinal function recovery time between the two groups (h, M ± SD).
| Group |
| Time to first anal discharge | Time to first postoperative bowel movement | Time to recovery of bowel sounds | Time to bed activity |
|---|---|---|---|---|---|
| CG | 22 | 23.56 ± 7.04 | 40.58 ± 11.36 | 20.47 ± 6.98 | 25.12 ± 8.35 |
| OG | 28 | 16.35 ± 4.25 | 29.65 ± 6.99 | 13.21 ± 2.87 | 14.25 ± 3.36 |
|
| 4.485 | 4.187 | 5.003 | 6.285 | |
|
| <0.05 | <0.05 | <0.05 | <0.05 |
Comparison of inflammatory factors between the two groups before and after treatment.
| Group |
| IL-8 (ng/L) | TNF- | ||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| CG | 22 | 85.31 ± 14.57 | 40.65 ± 6.98 | 30.06 ± 4.15 | 21.09 ± 4.68 |
| OG | 28 | 82.36 ± 12.54 | 30.65 ± 5.14 | 29.65 ± 4.12 | 15.74 ± 3.03 |
|
| 0.769 | 5.836 | 0.348 | 4.890 | |
|
| >0.05 | <0.05 | >0.05 | <0.05 | |
Comparison of negative emotions between the two groups before and after treatment.
| Group |
| SDS score | SAS score | ||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| CG | 22 | 69.55 ± 10.32 | 47.18 ± 6.23 | 66.18 ± 8.04 | 47.36 ± 4.07 |
| OG | 28 | 70.04 ± 11.32 | 37.21 ± 4.23 | 68.21 ± 9.93 | 35.11 ± 5.69 |
|
| 0.160 | 6.729 | 0.779 | 5.822 | |
|
| >0.05 | <0.05 | >0.05 | <0.05 | |
Figure 2(a) Comparison of SDS scores between the two groups of patients with gastrointestinal dysfunction after tumor surgery before and after treatment. (b) SAS score comparison between the two groups of patients with gastrointestinal dysfunction after tumor surgery before and after treatment.
Comparison of sleep quality between the two groups before and after treatment.
| Group |
| PSQ1 score | |
|---|---|---|---|
| Before | After | ||
| CG | 22 | 15.82 ± 2.87 | 10.82 ± 2.11 |
| OG | 28 | 16.64 ± 2.59 | 8.39 ± 1.17 |
|
| 1.060 | 5.174 | |
|
| >0.05 | <0.05 | |
Comparison of hospital stay and medical expenses between the two groups.
| Group |
| Length of hospital stay (d) | Medical expenses (ten thousand yuan) |
|---|---|---|---|
| CG | 22 | 13.05 ± 3.65 | 2.58 ± 0.34 |
| OG | 28 | 9.17 ± 1.68 | 1.67 ± 0.52 |
|
| 5.040 | 7.095 | |
|
| <0.05 | <0.05 |